Assessing the relationship between out-of-pocket spending on blood pressure and diabetes medication and household catastrophic health expenditure: evidence from Pakistan
Open Access
- 15 January 2019
- journal article
- research article
- Published by Springer Nature in International Journal for Equity in Health
- Vol. 18 (1) , 9
Abstract
Treatment of non-communicable diseases (NCDs) in low-and-middle-income countries (LMICs) is costly and could expose households to financial hardship and vulnerability. This paper examines the association between medication costs of two major NCDs – hypertension (blood pressure) and diabetes, and household-level incidences of catastrophic health expenditure (CHE) in a South Asian LMIC, Pakistan. The study analyzes self-reported blood pressure and diabetes (BPD) medication expenditure from the latest version (2015–16) of the Household Integrated Economic Survey (HIES) of Pakistan, a nationally representative survey of 24,238 households. The incidence of CHE is defined as households’ out-of-pocket (OOP) medical expenditure exceeding 10% of the total household expenditure. Using a linear probability model, we estimate the adjusted differences in CHE incidence between households that are spending and ‘not’ spending on BPD medication. We also analyze several hypothetical scenarios of BPD medication cost coverage, and compare the estimated CHE incidences of respective scenarios with the status quo. We find that the average monthly medical expenditure, and average medical expenditure share are significantly higher for households spending on BPD medication, compared to households ‘not’ spending. The incidence of CHE is found 6.7 percentage point higher for the households consuming BPD medication, after controlling for relevant socioeconomic attributes. If 25, 50, and 100% of the BPD medication OOP cost is covered, then the CHE incidence would reduce respectively by 5.9, 12.7, and 21.4% compared to the status quo. Medication cost for managing two major NCDs and household catastrophic health expenditure have strong associations. The findings inform policies toward ensuring access to necessary healthcare services, and protecting households from NCD treatment related financial hardship.Keywords
This publication has 14 references indexed in Scilit:
- Uncontrollable medicine prices in PakistanThe Lancet, 2016
- Diverse Empirical Evidence on Epidemiological Transition in Low- and Middle-Income Countries: Population-Based Findings from INDEPTH Network DataPLOS ONE, 2016
- Pakistan's health system: performance and prospects after the 18th Constitutional AmendmentThe Lancet, 2013
- Access to Essential Medicines in Pakistan: Policy and Health Systems Research ConcernsPLOS ONE, 2013
- Improving responsiveness of health systems to non-communicable diseasesThe Lancet, 2013
- Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declarationThe Lancet, 2013
- Overview2011
- Rethinking health-care systems: a focus on chronicityThe Lancet, 2011
- Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countriesThe Lancet, 2010
- Prevention of non-communicable diseases in Pakistan: an integrated partnership-based modelHealth Research Policy and Systems, 2004